- Scrip Originals
Brought to you by
Innovative Metabolics takes in $5.5mm via Series A round
11 Jun 2007
Anti-inflammatory device developer Innovative Metabolics (IMI) has raised $5.5mm in a Series A financing led by Morgenthaler Ventures. Foundation Medical Partners also participated.
- Medical Devices
- Venture Financing
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com